Nu Skin Enterprises, Inc. (NUS) financial statements (2021 and earlier)

Company profile

Business Address 75 WEST CENTER ST
PROVO, UT 84601
State of Incorp. DE
Fiscal Year End December 31
SIC 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments344398438368304300547
Cash and cash equivalents336387426357289288525
Short-term investments8111211141222
Receivables50533331353669
Inventory, net of allowances, customer advances and progress billings276296253250265338340
Inventory276296253250265338340
Prepaid expense1664115955 
Deferred costs8749   
Derivative instruments and hedges, assets  0102 
Deposits current assets11     
Prepaid expense and other current assets11
Other current assets16161413   
Other undisclosed current assets2822313043103152
Total current assets:7407997787147068351,118
Noncurrent Assets
Operating lease, right-of-use asset144
Property, plant and equipment454465465445455465396
Intangible assets, net (including goodwill), including:277287183143137188196
Goodwill197197115115112112112
Intangible assets, net (excluding goodwill)809068  7583
Other undisclosed intangible assets, net (including goodwill)   2825 
Other noncurrent assets154144165136165127 
Prepaid expense and other noncurrent assets111
Other undisclosed noncurrent assets   3542  
Total noncurrent assets:1,029895812760799780703
TOTAL ASSETS:1,7691,6941,5901,4741,5061,6141,821
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities329370370316340336709
Accounts payable39485041293583
Accrued liabilities290323319275311301626
Debt28697883688368
Deferred tax liabilities     0
Other undisclosed current liabilities      (0)
Total current liabilities:357440447399408418777
Noncurrent Liabilities
Long-term debt and lease obligation440361311334182165114
Long-term debt, excluding current maturities334361311334182165114
Operating lease, liability106
Liabilities, other than long-term debt97112127779112386
Deferred revenue and credits   7 
Asset retirement obligations     5 
Deferred tax liabilities, net    1614
Liability, pension and other postretirement and postemployment benefits     6
Other liabilities9711212777918972
Other undisclosed noncurrent liabilities     (34)(14)
Total noncurrent liabilities:537473438411273254186
Total liabilities:894913885810680672962
Stockholders' equity
Stockholders' equity attributable to parent875782705664826942859
Common stock0000000
Treasury stock, value(1,325)(1,327)(1,305)(1,250)(1,017)(863)(827)
Additional paid in capital558553466440420414397
Accumulated other comprehensive loss(85)(80)(66)(84)(71)(52)(46)
Retained earnings1,7281,6361,6091,5591,4941,4421,334
Total stockholders' equity:875782705664826942859
TOTAL LIABILITIES AND EQUITY:1,7691,6941,5901,4741,5061,6141,821

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues2,4202,6792,2792,2082,2472,4863,177
Revenue, net2,2792,2082,2472,4863,097
Cost of revenue
(Cost of Goods and Services Sold)
(581)(634)(502)(500)(490)(528)(506)
Other undisclosed gross profit     134 
Gross profit:1,8392,0451,7771,7071,7582,0912,671
Operating expenses(1,572)(1,804)(1,503)(1,476)(1,513)(1,739)(2,117)
Operating income:267241274231245352554
Nonoperating income (expense)(12)(21)(9)(18)(33)(54)3
Foreign currency transaction gain (loss), before tax(4)(16)3(9)(27)(54) 
Interest and debt expense(19)(7)(22)(16)(8)(13)(3)
Other undisclosed income from continuing operations before equity method investments, income taxes    8133
Income from continuing operations before equity method investments, income taxes:236212243197212299557
Other undisclosed income from continuing operations before income taxes1972216   
Income from continuing operations before income taxes:255220266213212299557
Income tax expense(82)(98)(136)(70)(79)(109)(192)
Net income available to common stockholders, diluted:174122129143133189365

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income:174122129143133189365
Other comprehensive income (loss)0(2)8(2)(0)4 
Other undisclosed comprehensive loss     (198)(359)
Comprehensive income (loss):174120137141133(5)6
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(6)(11)10(10)(20)189365
Comprehensive income, net of tax, attributable to parent:168108147130113184370

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: